Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:administeredBy |
topical
intravenous |
| gptkbp:alternativeName |
polymyxins
|
| gptkbp:discoveredBy |
gptkb:Bacillus_polymyxa
|
| gptkbp:mechanismOfAction |
disrupts bacterial cell membrane
|
| gptkbp:notEffectiveAgainst |
Gram-positive bacteria
|
| gptkbp:sideEffect |
nephrotoxicity
neurotoxicity |
| gptkbp:spectrumOfActivity |
Gram-negative bacteria
|
| gptkbp:subspecies |
gptkb:polymyxin_E
gptkb:polymyxin_B |
| gptkbp:usedFor |
treatment of Gram-negative bacterial infections
|
| gptkbp:WHOStatus |
gptkb:World_Health_Organization_List_of_Essential_Medicines
|
| gptkbp:bfsParent |
gptkb:Paenibacillus_polymyxa
gptkb:ARN_protein |
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
polymyxin
|